> ## Content Index > Fetch the complete content index at: https://stack-rundown.ghost.io/llms.txt > Use this file to discover other available public pages before exploring further. # AI Risk Adjustment Platforms for Health Plans - URL: https://stack-rundown.ghost.io/ai-risk-adjustment-platforms-for-health-plans/ - Published: 2026-08-21T01:44:15.000Z - Updated: 2026-09-08T19:00:29.000Z - Description: This is a 6-way comparison in name only. Only RAAPID publishes enough workflow detail to judge; Cotiviti, Edifecs, Inovalon, Reveleer, and Episource still need a demo. - Author: SR Staff - Tags: AI Tools **If I had to boil this down to one point, it’s this:** [***RAAPID***](https://www.raapidinc.com/?ref=stack-rundown.ghost.io) ***is the only vendor in this article with enough public detail to judge in a meaningful way.*** Everyone else may still be worth a look, but based on the article alone, I can’t verify much beyond partial feature claims. Here’s the short version: - **RAAPID** has the clearest public detail on **retrospective coding**, **suspecting**, **member stratification**, and **RADV workflow** - [**Cotiviti**](https://www.cotiviti.com/?ref=stack-rundown.ghost.io) looks strongest on **multi-source, longitudinal suspecting** - [**Edifecs**](https://www.edifecs.com/?ref=stack-rundown.ghost.io) stands out for **NLP review of unstructured notes** - [**Inovalon**](https://www.inovalon.com/?ref=stack-rundown.ghost.io)**,** [**Reveleer**](https://www.reveleer.com/?ref=stack-rundown.ghost.io)**, and Episource** need a **live demo** because public detail is thin - The main buying test is simple: **Can the platform support coding, source-text proof, MEAT logic, and RADV review without extra manual work?** The article also points to the pressure behind this choice. [CMS](https://www.cms.gov/about-cms?ref=stack-rundown.ghost.io) RADV activity has grown from **about 60 MA contracts per year to about 550**, and AI-assisted chart review can drop review time from **40+ minutes to under 8 minutes per chart**. So if you’re choosing a platform, I’d focus on: - **Retrospective coding** - **Pre-visit suspecting** - **Member prioritization** - **Audit trail quality** - **Chart review flow** - **Provider outreach** - **Contract-level reporting** ## AI in Risk Adjustment – Maximizing Accuracy & Compliance ###### sbb-itb-fd683fe ## Quick Comparison ![AI Risk Adjustment Platforms Compared: RAAPID vs. Cotiviti vs. Edifecs & More](https://assets.seobotai.com/undefined/6a879871dc1e9c396e6c9281-1787276127077.jpg) AI Risk Adjustment Platforms Compared: RAAPID vs. Cotiviti vs. Edifecs & More | Platform | Retrospective Coding | Suspecting | Member Prioritization | Audit / RADV Support | What I’d Watch | | ------------- | --------------------------------------------- | ------------------------------- | --------------------- | --------------------------------- | ------------------------------------------------- | | **RAAPID** | Yes, with adds/deletes and MEAT-linked review | Yes, before and after visit | Yes | Yes, with dedicated RADV workflow | Public reporting and deployment detail not stated | | **Cotiviti** | Limited public detail | Yes, based on longitudinal data | Yes | Limited public detail | Coding and audit flow need proof | | **Inovalon** | Not verified | Not verified | Not verified | Not verified | Needs demo and proof | | **Reveleer** | Not verified | Not verified | Not verified | Not verified | Check chart, coder, and reporting flow | | **Edifecs** | Yes, for note review support | Limited public detail | Limited public detail | Limited public detail | Best to verify depth beyond NLP | | **Episource** | Not verified | Not verified | Not verified | Not verified | Don’t rely on feature pages alone | **Bottom line:** if you want a clean side-by-side from public information, this article supports **RAAPID first**, **Cotiviti and Edifecs as partial fits**, and **the rest as demo-first evaluations**. That’s the frame I’d use before getting into the full comparison. ## 1\. [RAAPID](https://www.raapidinc.com/?ref=stack-rundown.ghost.io) ![RAAPID](https://assets.seobotai.com/stackrundown.com/6a879871dc1e9c396e6c9281/019e5436a6a35ef2e28867812e35499d.jpg) RAAPID is built around a **Neuro-Symbolic AI engine** that reads clinical context, not just keywords, to surface missed diagnoses and unsupported codes. The platform processes more than **8 million patient records per year** across over **100 healthcare clients**. ### Coding Support Here’s how RAAPID handles retrospective coding and prospective suspecting. RAAPID uses a two-way workflow to surface missed diagnoses and flag unsupported codes for review. Its **OnePass Challenge** ties each diagnosis to chart evidence and MEAT rationale in a single pass, which cuts down on back-and-forth work. RAAPID reports **98% final accuracy** and compares that with an industry baseline below 30%. ### Member Stratification RAAPID builds [risk profiles](https://www.mezzi.com/?ref=stack-rundown.ghost.io) and member registries that support care management workflows. It flags high-risk members for outreach and supports HCC gap closure programs. That same risk profile also feeds prospective suspecting before the visit, so teams can go into the encounter with a clearer view of what may be missing. ### Suspecting Logic RAAPID delivers pre-visit summaries, in-workflow prompts, and pre-claim review to surface HCC gaps before the encounter closes. It plugs into EHR workflows, so suggestions show up where clinicians already work instead of forcing them into a separate system. Once a code is suggested, the next step is simple: can it hold up in an audit? ### Audit and Reporting Every code links back to source documentation and MEAT evidence, which creates an audit trail for internal review or RADV response. The platform also includes a dedicated RADV audit solution that runs evidence-first checks, manages response workflows, and generates export files with clear audit trails. RAAPID also earned [KLAS](https://engage.klasresearch.com/?ref=stack-rundown.ghost.io) Emerging Company Spotlight recognition in May 2026. Key benchmarks are below. | Metric | Typical Benchmark | RAAPID | | ----------------- | ----------------- | ---------- | | Final Accuracy | \~95% | 98% | | Chart Review Time | \>40 minutes | <8 minutes | | ROI | N/A | 10:1 | ## 2\. [Cotiviti](https://www.cotiviti.com/?ref=stack-rundown.ghost.io) ![Cotiviti](https://assets.seobotai.com/stackrundown.com/6a879871dc1e9c396e6c9281/394369d33ba09ea3eddea777ab9f22ec.jpg) Cotiviti’s main strength in risk adjustment comes from [**DxCG Intelligence**](https://www.cotiviti.com/solutions/risk-adjustment/dxcg-intelligence?ref=stack-rundown.ghost.io) and its use of longitudinal data analysis. The platform pulls together claims, pharmacy, lab, and clinical data to build member risk profiles. Those profiles then feed its suspecting work. ### Coding Support The public detail here leans much more toward suspecting and member profiling. There’s less public detail on coding controls and the audit workflow itself. ### Member Stratification Cotiviti combines claims, pharmacy, lab, and clinical data to build longitudinal member risk profiles. ### Suspecting Logic Those profiles support suspecting by surfacing patterns across multiple years of data. ### Audit and Reporting For health plans, Cotiviti is most relevant when the main priority is longitudinal suspecting based on multi-source data. In this comparison, Cotiviti stands out more for **data-driven suspecting** than for documented coding workflow detail. Next, Inovalon adds a more complete view of coding support, audit controls, and reporting depth. ## 3\. [Inovalon](https://www.inovalon.com/?ref=stack-rundown.ghost.io) Public sources don't provide enough verified detail to judge Inovalon's risk-adjustment capabilities. That makes a side-by-side comparison hard, especially for coding, suspecting, audit readiness, and reporting depth. Next, Reveleer has more publicly documented workflow detail. ## 4\. [Reveleer](https://www.reveleer.com/?ref=stack-rundown.ghost.io) ![Reveleer](https://assets.seobotai.com/stackrundown.com/6a879871dc1e9c396e6c9281/532186ee1a25b794c5a0b16a380eb965.jpg) Public information on Reveleer is pretty limited. So if you're evaluating it, **double-check the workflow details that matter most for risk adjustment**. ### Coding Support Look closely at chart retrieval, coder workflow controls, MEAT support, and provider review workflows. Those pieces shape how smoothly coding work moves from intake to final review. ### Member Stratification Ask whether the platform can prioritize members based on risk, provider opportunity, encounter submission rates, and care-gap closure rates. That kind of sorting can make a big difference when teams need to focus their time where it counts. ### Suspecting Logic Prospective suspecting should surface undocumented or missing conditions *before* review starts. If that step happens too late, teams can lose time chasing charts without a clear path. ### Audit and Reporting You'll also want a clear evidence trail, plus reporting at the contract, provider, and member levels. If reporting is thin, it's harder to trace decisions and spot gaps. Next, Edifecs offers another comparison point for plans weighing coding support, suspecting, and audit reporting. ## 5\. [Edifecs](https://www.edifecs.com/?ref=stack-rundown.ghost.io) ![Edifecs](https://assets.seobotai.com/stackrundown.com/6a879871dc1e9c396e6c9281/6ada0f6221daa3175871e81d3157fb1d.jpg) Edifecs uses [Talix NLP](https://www.edifecs.com/blog/edifecs-acquires-health-fidelity-talix?ref=stack-rundown.ghost.io) to pull HCC-eligible conditions from unstructured notes that claims-only reviews often miss. It stands out for plans that need NLP-led review of note-heavy charts. ### Coding Support It scans unstructured clinical notes for HCC-eligible conditions and flags MEAT evidence for coder review. Public info is thinner when it comes to member stratification, suspecting logic, and reporting controls. Next, Episource adds another point of comparison for plan teams reviewing AI-driven risk adjustment workflows. ## 6\. Episource Public detail on Episource's risk adjustment platform is limited. So if you're a health plan comparing vendors, don't lean too hard on feature pages alone. **A live demo matters more than marketing copy.** When public docs are thin, verified workflow proof carries more weight than feature claims. That means plan teams should use the demo to check how the platform handles the work that affects day-to-day use, audit prep, and team output. In practice, that includes confirming workflows like: - chart retrieval - coder review - MEAT support - provider queries - suspecting logic - RADV readiness - reporting The comparison below is meant to help teams verify which vendors show these workflows most clearly. The next section compares these vendors on capability depth, audit support, and reporting. ## Feature Comparison and Pros and Cons Public sources only give enough detail for **RAAPID**. When you see `-`, it means that point wasn't stated in the source material. The table below draws a clean line between what's publicly documented and what still needs to be checked in a demo. | Platform | Coding Support | Member Stratification | Suspecting Logic | Audit Support | Reporting Depth | Deployment | Best-Fit Plan Type | | ----------------- | ---------------------------------------------- | -------------------------------------------------- | ----------------------------- | ----------------------------------------- | --------------------------- | --------------------------- | ------------------------------------ | | **RAAPID** | Two-way coding (adds and deletes), MEAT-backed | EHR-integrated pre-visit planning, HCC gap closure | Prospective and retrospective | Dedicated RADV solution, OnePass workflow | \- | \- | Medicare Advantage, value-based care | | **Other vendors** | Public detail not specified | Public detail not specified | Public detail not specified | Public detail not specified | Public detail not specified | Public detail not specified | Verify in demo | RAAPID is the only vendor with enough public detail to score cleanly. The other vendors need direct verification. Put simply, **RAAPID is the only platform here with clearly documented two-way coding and documented RADV workflow depth**. | Platform | Pros | Cons | | ----------------- | ---------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------- | | **RAAPID** | Two-way coding helps limit over-coding; prospective and retrospective workflows; 98% final accuracy and 10:1 ROI are claimed | Reporting depth and deployment model are not stated in the provided sources | | **Other vendors** | Pros and cons not verified in the provided sources | \- | Use demos to verify the workflow areas that the public record does not fully document. ## How to Choose the Right Platform for Your Health Plan Use these criteria to separate feature claims from workflows that will actually hold up in review. Start with your line of business. If your plan is mainly Medicare Advantage, the platform should support MA-specific files such as X12 837 I/P/D, MAO-002, MAO-004, MMR, and MOR. If your plan has a large ACA Marketplace footprint, make sure it supports EDGE Server XML for Enrollment, Medical, Pharmacy, Supplemental Diagnosis, and RA/RI Calculation Reports. That check can help cut lost revenue tied to rejected records. Then look at the deployment model. Software-only can be a good fit when you have a strong internal coding team and want AI to cut documentation burden and move cases through faster. Managed services pair AI software with chart retrieval and professional coding. That setup makes more sense when your plan doesn't have the setup for nationwide chart retrieval or needs to scale outreach-heavy prospective programs without adding staff. After line-of-business fit, compare how each platform finds and validates risk. ### Retrospective Coding vs. Prospective Suspecting Use closed-chart tools for retrospective work tied to submission deadlines. Use point-of-care tools for prospective gap closure. For SNPs, put EHR-integrated tools near the top of the list so care gaps surface during the visit, not after it. ### Evidence Trail, MEAT Support, and Coder Review Controls Require source-text traceability, reviewer accept/reject controls, automated MEAT support, and a complete audit trail. If a diagnosis gets challenged later, you don't want to hunt through the system trying to figure out where it came from. Once workflow fit is clear, check how each platform handles audit defense. ### RADV Readiness and Internal Audit Workflow Ask how the platform handles deletion workflows, audit sampling, export files, and RADV-ready modules. Those details matter when teams have to respond under pressure. ### Reporting by Contract, Provider, and Member Look for reporting by contract, provider, and member, with drill-down into RAF drivers. High-level dashboards are nice, but they don't help much if you can't trace what changed, where it changed, and who it affects. ## Buyer Questions and Buying Priorities Use the comparison above to pressure-test vendor claims on the workflows that matter most for audit defensibility. A slick demo can hide weak spots. The real test is whether the platform can stand up when auditors start pulling threads. For **adds and deletes**, ask vendors to show how the system ties differences back to source claims, encounters, and member data. Get specific about real-time alerts for rejected or failed records in MAO-002, MAO-004, and EDGE Server files. If the answer stays high level, that’s a red flag. For **prospective suspecting**, ask whether the platform can send undocumented HCC alerts straight into your EHR workflow for pre-visit planning. Some tools only show gaps after the visit, which limits what providers can do in the moment. For **coder controls**, ask for a live demo of source-linked evidence. You want to see the exact chart text that supports a suggested code, not just a code recommendation with no trail. That difference matters when teams need to defend coding choices later. For **RADV readiness**, ask whether the platform has a pre-submission audit scrubber that flags unsupported diagnoses before submission to CMS. That step can make the difference between a clean process and a painful cleanup. Also confirm HIPAA controls, ISO 27001, and support for the current CMS-HCC model. Those are table stakes. Turn the answers into a simple buying checklist: - **Retrospective programs:** Put two-way AI coding first, along with MEAT-backed rationale and clear coder accept/reject controls. - **Prospective outreach:** Put EHR integration depth first, plus tools that cut documentation burden for clinical staff with less provider friction. - **RADV exposure:** Let the audit trail and MEAT evidence features decide it, not the dashboard. The conclusion below distills the main tradeoffs by plan need. ## Conclusion The comparison comes down to one simple rule: **pick the platform that fits the workflow where your plan carries the most risk**. Risk adjustment platforms don’t all lean the same way. Some put more weight on automation and scale. Others give you tighter coding control, stronger prospective suspecting, or better audit defense. The right choice is the one that lines up with the process most likely to create problems for your organization. Start with your biggest point of exposure: retrospective coding, prospective suspecting, or RADV defense. If retrospective coding volume is the main issue, pay close attention to MEAT support and coder review controls. If prospective gap closure matters more, look hard at EHR integration depth and pre-visit planning tools. If RADV readiness is the top concern, audit trail quality and submission reconciliation features should carry more weight. With CMS expanding MA contract audits from about 60 per year to roughly 550, picking the wrong tool can hit both your margins and your day-to-day work. Treat platform selection as an operating decision. The best tool is the one that fits your coding, clinical, and compliance workflows. ## FAQs ### What should a health plan verify in a live demo? Health plans should check for end-to-end risk adjustment support across the full workflow. That means looking for: - **Prospective suspecting and patient stratification** that use the same RAF or risk engine - **Retrospective chart review** connected to structured claims and encounter data - **RADV-focused validation** built around CMS-style audit logic, including issues like unsupported HCCs, coding inconsistencies, and date-of-service problems - **Lifecycle traceability** from visit to submission, along with **audit-ready reporting** ### How do retrospective coding and prospective suspecting differ? **Retrospective coding** happens after a visit or other service. AI looks back through charts and documents to pull out diagnoses, spot coding gaps, and support chart-to-encounter checks and RADV audit readiness. **Prospective suspecting** happens earlier in the process. AI uses past data and predictive signals to flag members who may be under-coded, so care teams can focus on the right patients and possible HCCs before submission. ### Which features matter most for RADV readiness? The most important feature is **continuous scrubbing of encounter data and Chart Review Records before submission to CMS**. That matters because bad data at the front end can turn into billing trouble later. A strong platform checks records on a steady basis, catches issues early, and helps teams fix them before they become bigger problems. Strong platforms should also use **one RAF score engine** across the workflow so scoring stays consistent. On top of that, they should flag **unsupported diagnoses** and **high-risk coding issues** before those issues make it downstream. Just as important, the platform needs to provide **full traceability** from the patient visit to final audit resolution. In plain English: you should be able to follow the trail from the original encounter all the way through the final outcome. That keeps results explainable and easier to defend during review. ## Related Blog Posts - [How AI Automates Billing for SaaS Companies](https://stack-rundown.ghost.io/ai-automates-billing-saas-companies/) - [Best AI Tools for Payment Fraud Detection 2026](https://stack-rundown.ghost.io/best-ai-tools-payment-fraud-detection/) - [10 Key Features in Data Catalog Software](https://stack-rundown.ghost.io/data-catalog-software-key-features/) - [12 Legal Document Automation Tools for 2026](https://stack-rundown.ghost.io/best-legal-document-automation-tools/) --- ## More on StackRundown Continue on the [AI Tools hub](https://stack-rundown.ghost.io/ai-tools/), or read next: - [AI Risk Tool Checklist for Buyers (2026 Guide)](https://stack-rundown.ghost.io/ai-risk-tool-checklist-for-buyers/)